Expression of TPT1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

TPT1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2660.11

Median expressionⁱ : 2852.01

Median follow up timeⁱ : 0.98

P scoreⁱ 0.42

3-year survival highⁱ 9%

3-year survival lowⁱ 10%

TCGA RNA samplesⁱ

Average TPM

3172.2

Number of samples

141

Samples

Sample	Description	TPM
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	10378.4
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	10183.3
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	8917.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	7030.3
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	6537.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	6413.7
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	6198.9
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	6174.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	6035.9
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	5572.6
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	5159.4
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	5054.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	5007.1
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	4892.2
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4870.5
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	4819.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	4699.4
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	4666.0
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	4617.4
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	4467.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	4330.9
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4317.7
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	4227.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	4209.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	4166.7
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	4111.5
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	4073.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	4040.8
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	4020.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	3904.2
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3790.7
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3776.0
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	3707.4
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	3667.9
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	3652.5
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3575.5
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3571.2
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3501.4
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3497.3
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	3482.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3453.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3421.0
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	3411.9
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	3366.1
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	3335.3
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	3328.2
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3324.5
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	3290.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	3288.4
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	3267.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3253.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3239.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3198.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3149.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	3128.5
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3082.0
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3080.7
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	3080.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	3074.1
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	3067.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	3064.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	3063.9
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3050.0
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3018.4
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2957.3
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2936.3
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2917.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2917.6
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2883.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2859.6
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2852.0
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2799.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2798.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2784.5
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2771.4
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2762.0
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2746.6
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2730.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2710.7
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2710.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2671.5
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	2665.9
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2654.3
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2648.6
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2630.7
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2604.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	2583.4
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2582.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2574.8
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2556.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2499.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2475.9
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2416.2
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2404.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	2400.2
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2395.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2378.0
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2338.5
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2324.2
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2307.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	2288.1
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2281.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2231.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2228.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2210.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2209.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2206.2
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2176.7
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2169.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	2157.8
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	2138.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	2127.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2123.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	2104.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	2074.2
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	2065.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1988.9
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1978.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1951.4
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1946.5
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1945.8
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1944.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1885.2
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1869.3
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1844.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1834.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1826.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1732.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1725.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1724.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1674.7
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1627.3
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1571.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1570.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1420.8
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1331.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1273.1
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1270.6
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1164.8
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1061.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	729.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

TPT1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 234.7

Median expressionⁱ : 212.48

Median follow up timeⁱ : 0.99

P scoreⁱ 0.069

3-year survival highⁱ 0%

3-year survival lowⁱ 35%

TCGA RNA samplesⁱ

Average TPM

214.3

Number of samples

Samples

Sample	Description	TPM
AK030	N, NA, stage:NA, dead, 120 days	375.7
AK195	N, NA, stage:NA, dead, 390 days	366.1
AK188	N, NA, stage:NA, alive, 420 days	361.0
AK185	N, NA, stage:NA, alive, 330 days	359.0
AK139	N, NA, stage:NA, dead, 270 days	328.2
AK066	N, NA, stage:NA, alive, 960 days	318.1
AK142	N, NA, stage:NA, alive, 90 days	301.8
AK178	N, NA, stage:NA, dead, 240 days	300.3
AK055	N, NA, stage:NA, dead, 240 days	294.2
AK236	N, NA, stage:NA, dead, 360 days	282.4
AK153	N, NA, stage:NA, dead, 240 days	278.6
AK218	N, NA, stage:NA, dead, 180 days	267.7
AK098	N, NA, stage:NA, dead, 660 days	263.7
AK088	N, NA, stage:NA, dead, 360 days	263.7
AK133	N, NA, stage:NA, dead, 360 days	263.4
AK231	N, NA, stage:NA, dead, 240 days	260.3
AK005	N, NA, stage:NA, dead, 240 days	237.2
AK117	N, NA, stage:NA, dead, 210 days	236.6
AK183	N, NA, stage:NA, alive, 360 days	232.8
AK074	N, NA, stage:NA, alive, 300 days	231.0
AK071	N, NA, stage:NA, dead, 540 days	230.5
AK002	N, NA, stage:NA, dead, 570 days	224.6
AK165	N, NA, stage:NA, alive, 360 days	222.9
AK173	N, NA, stage:NA, dead, 180 days	218.8
AK199	N, NA, stage:NA, alive, 1860 days	218.7
AK124	N, NA, stage:NA, alive, 1920 days	218.7
AK134	N, NA, stage:NA, dead, 360 days	216.6
AK072	N, NA, stage:NA, dead, 150 days	216.1
AK049	N, NA, stage:NA, dead, 180 days	213.7
AK003	N, NA, stage:NA, dead, 600 days	211.3
AK227	N, NA, stage:NA, alive, 300 days	209.4
AK051	N, NA, stage:NA, dead, 360 days	208.0
AK158	N, NA, stage:NA, dead, 360 days	203.6
AK213	N, NA, stage:NA, alive, 2010 days	198.3
AK167	N, NA, stage:NA, dead, 180 days	198.0
AK043	N, NA, stage:NA, alive, 660 days	190.5
AK205	N, NA, stage:NA, dead, 120 days	189.2
AK079	N, NA, stage:NA, dead, 210 days	187.4
AK015	N, NA, stage:NA, alive, 720 days	180.2
AK156	N, NA, stage:NA, dead, 330 days	175.3
AK099	N, NA, stage:NA, dead, 420 days	172.0
AK076	N, NA, stage:NA, alive, 660 days	171.3
AK089	N, NA, stage:NA, dead, 330 days	169.7
AK053	N, NA, stage:NA, dead, 300 days	162.1
AK123	N, NA, stage:NA, dead, 180 days	162.0
AK081	N, NA, stage:NA, dead, 180 days	159.1
AK035	N, NA, stage:NA, dead, 210 days	156.2
AK216	N, NA, stage:NA, dead, 360 days	156.0
AK068	N, NA, stage:NA, alive, 360 days	154.2
AK100	N, NA, stage:NA, alive, 960 days	150.6
AK091	N, NA, stage:NA, dead, 210 days	150.0
AK149	N, NA, stage:NA, dead, 420 days	143.0
AK006	N, NA, stage:NA, dead, 360 days	127.2
AK103	N, NA, stage:NA, alive, 1320 days	96.6
AK102	N, NA, stage:NA, alive, 1740 days	95.8
AK226	N, NA, stage:NA, dead, 360 days	93.8
AK085	N, NA, stage:NA, alive, 660 days	81.8
AK041	N, NA, stage:NA, alive, 810 days	79.2
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0089150003	Tumor	0.6
CPT0206230003	Tumor	0.5
CPT0087950003	Tumor	0.5
CPT0190360004	Tumor	0.5
CPT0221180003	Tumor	0.5
CPT0217710008	Tumor	0.5
CPT0206560003	Tumor	0.5
CPT0219080004	Tumor	0.4
CPT0217000004	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0205450004	Tumor	0.4
CPT0217060003	Tumor	0.4
CPT0093360003	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0217880003	Tumor	0.3
CPT0225760003	Tumor	0.2
CPT0079790003	Tumor	0.2
CPT0218770003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0168380003	Tumor	0.2
CPT0087730003	Tumor	0.1
CPT0206880003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0224330003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0204330003	Normal	0.1
CPT0217100003	Tumor	0.1
CPT0162020003	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0125570003	Tumor	0.1
CPT0204400003	Normal	0.0
CPT0087570003	Tumor	0.0
CPT0204380003	Normal	0.0
CPT0204390003	Normal	0.0
CPT0182500003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0204420003	Normal	0.0
CPT0186100003	Tumor	0.0
CPT0206780003	Tumor	0.0
CPT0224390004	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0104220003	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0204410003	Normal	0.0
CPT0168080003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0207090003	Tumor	-0.1
CPT0189650004	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0167860004	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0204340003	Normal	-0.1
CPT0218960004	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0196850003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0093450003	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0125510003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0204350003	Normal	-0.2
CPT0071100003	Tumor	-0.2
CPT0104330003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0204370003	Normal	-0.2
CPT0189250003	Tumor	-0.2
CPT0168270003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0218330004	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0224540004	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0218670003	Tumor	-0.3
CPT0167750004	Tumor	-0.3
CPT0218690004	Tumor	-0.3
CPT0171580008	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0002410011	Tumor	-0.4
CPT0207030003	Tumor	-0.4
CPT0228220003	Tumor	-0.4
CPT0208980003	Tumor	-0.4
CPT0168590003	Tumor	-0.4
CPT0161730003	Tumor	-0.5
CPT0206670004	Tumor	-0.5
CPT0190240004	Tumor	-0.5
CPT0092440003	Tumor	-0.5
CPT0201710003	Tumor	-0.6
CPT0218830004	Tumor	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA039437	Antibody HPA073929	Antibody CAB008364
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade